← brief for 2026-09-25 · Slowing decline

Finerenone Regulates Macrophage-Tubular Crosstalk in Diabetic Nephropathy via the AMPK/PKM2 Pathway.

Article D Peer reviewed Preclinical

Key takeaways

This study used mice and cells to see how a drug called finerenone works. It is not in people yet. It shows the drug may help by changing how immune cells talk to kidney cells.

Who did this work

Tang J · Zhu L

Source

Article · PubMed, the drug frontier · 2026 Jul
https://pubmed.ncbi.nlm.nih.gov/42790936/